本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

AROA BIOSURGERY LTD

0.615
+0.0050.82%
成交量:5.69万
成交额:3.48万
市值:2.12亿
市盈率:-60.67
高:0.620
开:0.605
低:0.605
收:0.610
52周最高:0.815
52周最低:0.350
股本:3.45亿
流通股本:2.59亿
量比:0.31
换手率:0.02%
股息:- -
股息率:- -
每股收益(TTM):-0.010
每股收益(LYR):-0.010
净资产收益率:-4.06%
总资产收益率:-1.66%
市净率:2.50
市盈率(LYR):-60.92

数据加载中...

公司资料

公司名字:
AROA BIOSURGERY LTD
交易所:
ASX
成立时间:
2007
员工人数:
- -
公司地址:
64 Richard Pearse Drive,Airport Oaks,Mangere,Auckland,New Zealand
邮编:
2022
电话:
传真:
- -
简介:
Aroa Biosurgery Limited designs and manufactures medical products, which enable surgeons and clinicians to repair serious tissue injuries. It offers Endoform, a high performance building block for developing a range of regenerative tissue substitutes to assist with tissue repair and healing; Endoform Dermal Template, an intact extracellular matrix to treat acute and chronic wounds from day one; and Reinforced Bioscaffolds, a surgical product that is primarily designed for use in ventral hernia repair and abdominal wall reconstruction. The company's products are distributed through medical technology companies. Aroa Biosurgery Limited was formerly known as Mesynthes Ltd. and changed its name to Aroa Biosurgery Limited in June 2015. The company was founded in 2007 and is based in Auckland, New Zealand.